Synovex Choice; Synovex Plus

Zoetis Inc

Revision date : 2013-10-15

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08
Health risk rating 5
Safety risk rating 1
Environmental risk rating 1

General Information

Revision date

2013-10-15

Product name

Synovex Choice; Synovex Plus

Chemical name

Steroid

Icons in SDS

GHS08

Company Information

company name

Zoetis Inc

e-mail address of the competent person responsible for the Safety Data Sheet

VMIPSrecords@zoetis.com

GHS Information

Signal word

Danger

Hazard Codes

Hazard statements (CLP)

H350, H360FD

Hazard statements

Code

Statements

H350

May cause cancer

Section 2

SECTION 2: Hazards identification

Appearance: Implant

2.1 Classification of the substance or mixture

Reproductive Toxicity: Category 1A Carcinogenicity: Category 1B

EU Classification

EU Indication of danger Carcinogenic Category 1 Toxic to reproduction: Category 1 EU Symbol: T EU Risk Phrases: R45 - May cause cancer. R60 - May impair fertility. R61 - May cause harm to the unborn child.

Signal word

Danger

Hazard statements

H360FD - May damage fertility. May damage the unborn child. H350 - May cause cancer

Precautionary statements

P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P280 - Wear protective gloves/protective clothing/eye protection/face protection P308 + P313 - IF exposed or concerned: Get medical attention/advice P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations

2.3 Other hazards

Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on reproductive system. Occupational studies have shown that males working with estrogen-like compounds have shown clinical signs of hyperestrogenism including enlarged breasts and milk secretion. Loss of libido, breast tenderness, and changes in sex hormone levels have also occurred. Occupational exposure in females has resulted in menstrual irregularities (breakthrough bleeding, menstrual flow changes, spotting and amenorrhea). Known Clinical Effects: This material causes changes in reproductive hormone levels resulting in inhibition of ovulation. Clinical use of this drug has resulted in the development of male characteristics in females. Australian Hazard Classification

Hazardous Ingredients

Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.